ES2189251T3 - Procedimiento de preparacion de diarilpiridinas utiles como inhibidores de cox-2'. - Google Patents

Procedimiento de preparacion de diarilpiridinas utiles como inhibidores de cox-2'.

Info

Publication number
ES2189251T3
ES2189251T3 ES98948426T ES98948426T ES2189251T3 ES 2189251 T3 ES2189251 T3 ES 2189251T3 ES 98948426 T ES98948426 T ES 98948426T ES 98948426 T ES98948426 T ES 98948426T ES 2189251 T3 ES2189251 T3 ES 2189251T3
Authority
ES
Spain
Prior art keywords
formula
compound
preparation
diarilpiridins
cox
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98948426T
Other languages
English (en)
Inventor
Ian W Davies
Linda Gerena
Michel Journet
Robert D Larsen
Philip J Pye
Kai Rossen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9806419.9A external-priority patent/GB9806419D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of ES2189251T3 publication Critical patent/ES2189251T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Un procedimiento para la preparación de compuestos de fórmula 5 R1 se selecciona del grupo constituido por (a) CH3, (b) NH2, (c) NHC(O)CF3, (e) NHCH3; y Ar es un fenilo o piridinilo (o el N-óxido de los mismos) mono-, di-, o trisustituídos, siendo los sustituyentes elegidos del grupo constituido por (a) hidrógeno, (b) halógeno, (c) alcoxi C1-4, (d) alquiltio C1-4, (e) CN, (f) alquilo C1-4, (g) fluoroalquilo C1-4, comprendiendo el procedimiento: hacer reaccionar un compuesto de fórmula 13 en la que X es un halógeno perteneciente al grupo constituido por yodo, cloro, bromo y flúor, con un compuesto de fórmula 9 para producir un compuesto de fórmula 15 y oxidar el compuesto de fórmula 15 usando un agente oxidante, y opcionalmente un catalizador y un ácido para producir un compuesto de fórmula 5.
ES98948426T 1997-09-25 1998-09-22 Procedimiento de preparacion de diarilpiridinas utiles como inhibidores de cox-2'. Expired - Lifetime ES2189251T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6068097P 1997-09-25 1997-09-25
GBGB9806419.9A GB9806419D0 (en) 1998-03-25 1998-03-25 Process for making diaryl pyridines useful as cox-2 inhibitors

Publications (1)

Publication Number Publication Date
ES2189251T3 true ES2189251T3 (es) 2003-07-01

Family

ID=26313354

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98948426T Expired - Lifetime ES2189251T3 (es) 1997-09-25 1998-09-22 Procedimiento de preparacion de diarilpiridinas utiles como inhibidores de cox-2'.

Country Status (14)

Country Link
EP (1) EP1023266B1 (es)
JP (2) JP3325263B2 (es)
CN (1) CN1134415C (es)
AR (1) AR015938A1 (es)
AT (1) ATE230726T1 (es)
AU (1) AU9500298A (es)
BR (1) BR9812837B1 (es)
CZ (1) CZ298850B6 (es)
DE (1) DE69810652T2 (es)
DK (1) DK1023266T3 (es)
EA (1) EA002427B1 (es)
ES (1) ES2189251T3 (es)
SK (1) SK283811B6 (es)
WO (1) WO1999015503A2 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141673B1 (en) 1999-01-14 2006-11-28 Lonza Ag 1-(6-methylpyridine-3-yl)-2-[4-(methylsulphonyl) phenyl] ethanone and method for its preparation
PT1394149E (pt) * 1999-01-14 2005-05-31 Lonza Ag Processo para a producao de 1-(6-metilpiridin-3-il)-2-[4-(metilsulfonil)fenil]etanona
JP3032980B1 (ja) 1999-06-14 2000-04-17 三協化学株式会社 ２―ピリジルピリジン誘導体の製造方法
EP1198455B1 (en) * 1999-07-27 2003-12-10 Lonza AG Process for preparing 1-(6-methylpyridin-3-yl)-2- (4-(methylsulphonyl) phenyl] ethanone
US6566527B1 (en) 1999-07-27 2003-05-20 Merck & Co., Inc. Process for preparing 1-(6-methylpyridin-3-yl)-2-[4-methylsulphonyl)-phenyl]ethanone
JP2001115963A (ja) 1999-10-13 2001-04-27 Daikin Ind Ltd 圧縮機
IT1315244B1 (it) * 1999-10-15 2003-02-03 Zambon Spa Processo per la preparazione di intermedi utili nella sintesi didiarilpiridine
IT1315243B1 (it) * 1999-10-15 2003-02-03 Zambon Spa Processo di ossidazione per la preparazione di intermedi utili nellasintesi di diarilpiridine
JP2001261646A (ja) * 2000-03-17 2001-09-26 Sankio Chemical Co Ltd ピリジン誘導体の製造法
JP2001261647A (ja) * 2000-03-22 2001-09-26 Sankio Chemical Co Ltd ピリジン誘導体の製造方法
WO2002007721A2 (en) 2000-07-20 2002-01-31 Lauras As Use of cox-2 inhibitors for preventing immunodeficiency
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
ITMI20012692A1 (it) * 2001-12-19 2003-06-19 Zambon Spa Processo di ossidazione per la preparazione di intermedi utili nella sintesi di diarilpiridine
US7507823B2 (en) 2004-05-06 2009-03-24 Bristol-Myers Squibb Company Process of making aripiprazole particles
EP2582690B1 (en) * 2010-06-16 2018-07-25 Glenmark Generics Limited Process for preparation of 2, 3-diaryl-5-substituted pyridines and their intermediates
MY163379A (en) * 2010-11-15 2017-09-15 Virdev Intermediates Pvt Ltd A process for cyclooxygenase-2 selective inhibitor
ITMI20110362A1 (it) * 2011-03-09 2012-09-10 F I S Fabbrica Italiana Sint P A Procedimento per la preparazione di 1-(6-metilpiridin-3-il)-2-[4-(metilsolfonil)fenil]etanone, un intermedio dell'etoricoxib.
CN102276517B (zh) * 2011-06-29 2012-11-28 孙光辉 二芳基吡啶类药物的合成方法
ITMI20111455A1 (it) 2011-07-29 2013-01-30 Italiana Sint Spa Nuovo procedimento per la preparazione di 1-(6-metilpiridin-3-il)-2-[4-(metilsolfonil)fenil]etanone, un intermedio dell'etoricoxib.
WO2013065064A1 (en) * 2011-10-31 2013-05-10 Sequent Scientific Limited A process for preparation of l-(6-methylpyridin-3-yl)-2-[4-(meth.ylsulfonyi)phenyl]ethanone field of invention
CN103204803A (zh) * 2012-01-13 2013-07-17 阿尔弗雷德·E·蒂芬巴赫尔有限责任两合公司 用于合成依托考昔的方法
ITMI20121947A1 (it) * 2012-11-15 2014-05-16 Erregierre Spa Processo di sintesi di un intermedio nella produzione di etoricoxib
ITVI20130014A1 (it) 2013-01-22 2014-07-23 Italiana Sint Spa Procedimento molto efficiente per preparare un intermedio di etoricoxib
CN104418799A (zh) * 2013-09-03 2015-03-18 天津药物研究院 一种依托考昔的晶型及其制备方法和应用
WO2015036550A1 (en) * 2013-09-13 2015-03-19 Synthon B.V. Process for making etoricoxib
CN104529798B (zh) * 2014-12-10 2016-03-30 齐鲁天和惠世制药有限公司 一种依托考昔中间体3-氨基-2-氯丙烯醛的制备方法
CH712810B1 (de) * 2015-07-21 2020-07-15 Sumitomo Chemical Co Verfahren zur Herstellung einer 4-(Trifluormethylsulfonyl)phenol-Verbindung.
CN108689917A (zh) * 2017-04-08 2018-10-23 深圳市华先医药科技有限公司 一种依托考昔中间体连续流生产工艺
CN109810052B (zh) * 2017-11-20 2020-06-23 新发药业有限公司 一种高选择性的阿帕替尼的简便制备方法
CN112300061B (zh) * 2020-10-06 2022-02-18 大连理工大学 一种含氮杂环二芳酮化合物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3277103A (en) * 1961-06-29 1966-10-04 Du Pont beta-amino-alpha-cyanoacroleins and their preparation
US4242515A (en) * 1979-03-28 1980-12-30 American Cyanamid Company Substituted 3-alkyl-6-phenyl-1,2,4-triazolo-[4,3-a]pyridines
CH660733A5 (de) * 1981-09-29 1987-06-15 Lonza Ag Verfahren zur herstellung von 3-picolin.
DE3634259A1 (de) * 1986-10-08 1988-04-21 Basf Ag Verfahren zur herstellung von substituierten pyridinen
EP0548559A1 (en) * 1991-12-27 1993-06-30 American Cyanamid Company Process for the preparation of dialkyl pyridine -2,3-dicarboxylates and derivatives thereof from dialkyl dichloromaleate
US5593994A (en) 1994-09-29 1997-01-14 The Dupont Merck Pharmaceutical Company Prostaglandin synthase inhibitors
US5686470A (en) * 1995-02-10 1997-11-11 Weier; Richard M. 2, 3-substituted pyridines for the treatment of inflammation
RO119946B1 (ro) 1995-02-13 2005-06-30 G.D. Searle & Co. Derivaţi de izoxazol, utilizaţi pentru tratamentul inflamaţiilor
TW492959B (en) 1997-04-18 2002-07-01 Merck & Co Inc Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors

Also Published As

Publication number Publication date
JP4157325B2 (ja) 2008-10-01
SK283811B6 (sk) 2004-02-03
CN1134415C (zh) 2004-01-14
WO1999015503A2 (en) 1999-04-01
ATE230726T1 (de) 2003-01-15
EP1023266A2 (en) 2000-08-02
WO1999015503A3 (en) 1999-05-20
EA002427B1 (ru) 2002-04-25
EP1023266B1 (en) 2003-01-08
SK4222000A3 (en) 2000-10-09
BR9812837A (pt) 2000-08-08
DE69810652D1 (de) 2003-02-13
HK1029343A1 (en) 2001-03-30
JP3325263B2 (ja) 2002-09-17
DE69810652T2 (de) 2003-10-09
CN1278795A (zh) 2001-01-03
EA200000358A1 (ru) 2000-10-30
AR015938A1 (es) 2001-05-30
CZ20001088A3 (cs) 2000-09-13
CZ298850B6 (cs) 2008-02-27
JP2003026687A (ja) 2003-01-29
AU9500298A (en) 1999-04-12
JP2001517654A (ja) 2001-10-09
BR9812837B1 (pt) 2010-08-24
DK1023266T3 (da) 2003-02-24

Similar Documents

Publication Publication Date Title
ES2189251T3 (es) Procedimiento de preparacion de diarilpiridinas utiles como inhibidores de cox-2'.
ES477008A1 (es) Procedimiento para la preparacion de difenileteres.
DK283589A (da) 1-indolylalkyl-4-(substitueret pyridinyl)-piperaziner
ES8704872A1 (es) Un procedimiento para preparar aril-hidroxamatos
ES8605791A1 (es) Un procedimiento para la preparacion de derivados de imida- zodiacepina
ES2163512T3 (es) Nuevo compuesto, procedimiento para producirlo, y agente antitumoral.
ES8601992A1 (es) Procedimiento para preparar 2-fenil-imidazoles
ES8600211A1 (es) Un procedimiento para la preparacion de nuevos derivados arilfenilicos
ES8801222A1 (es) Un procedimiento para la preparacion de nuevos derivados de ciclopenta(d)pirimidina
ES8304070A1 (es) "procedimiento para la preparacion de nuevas amidas de acidos carboxilicos".
AR033427A1 (es) Uso de compuestos carbamatos en el tratamiento del dolor
AR018877A1 (es) Un procedimiento para la preparacion de derivados de morfolina
ES8604164A1 (es) Procedimiento para preparar nuevos bencimidazoles
ES8303296A1 (es) "procedimiento para obtener n-(halogenometil) acilamidas".
SE7605819L (sv) Nya propargyl-2-fenylaminoimidazolin-(2), dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav
ES2058150T3 (es) Procedimiento para la obtencion de productos de reaccion del 2,2-bis(4-hidroxifenil)hexafluorpropano asi como estos nuevos derivados.
ES8105997A1 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ES8607279A1 (es) Un procedimiento para preparar una quinolona
ES8702390A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,5-benzotiazepina
ES8708139A1 (es) Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas.
ES8205215A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido acetico.
ES528374A0 (es) Procedimiento para la obtencion de enantiomeros dextrogiro de derivados de acido fenoxipropionico
ES2042552T3 (es) Derivados de indenopirimidina.
ES8203896A1 (es) Procedimiento para preparar 2,3-dihidroimidazo(1,2-b)pirida-zinas
ES8407482A1 (es) Un procedimiento para la preparacion de nuevos derivados de acidos alquiloxazolilaceticos.